Experts from the University of of Dundee's Centre for Targeted Protein Degradation (CeTPD), working with Boehringer Ingelheim scientists, have developed a breakthrough small-molecule drug ...

Experts have developed a breakthrough small-molecule drug, a 'protein degrader'. This molecule, called ACBI3, could potentially lead to new therapies independent of KRAS mutation type, improving ...

For years, scientists thought they had a good grasp on what happens when a molecule of water meets air. You know, the stuff we read in textbooks? Turns out, we’ve been wrong. A group of researchers ...

Photosynthetic parameters such as maximum rate of carboxylation of RuBP (V cmax) and the maximum rate of electron transport driving RuBP regeneration (J max) have been identified as ideal targets for ...

Add a description, image, and links to the molecule-driver topic page so that developers can more easily learn about it.